These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32709493)

  • 1. Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease.
    Elorza A; Rodríguez-Lago I; Martínez P; Hidalgo A; Aguirre U; Cabriada JL
    Gastroenterol Hepatol; 2020 Dec; 43(10):614-619. PubMed ID: 32709493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the incidence of inflammatory bowel disease in Southern Spain.
    Chaaro Benallal D; Guerra Veloz MF; Argüelles-Arias F; Benítez JM; Perea Amarillo R; Iglesias E; Castro Laria L; Sánchez García V; Maldonado Pérez MB; Vilches Á; Caunedo Álvarez Á; Romero Gómez M
    Rev Esp Enferm Dig; 2017 Nov; 109(11):757-760. PubMed ID: 28776379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
    Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
    Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study.
    Lobatón T; Hoffman I; Vermeire S; Ferrante M; Verhaegen J; Van Assche G
    Inflamm Bowel Dis; 2015 Jan; 21(1):71-8. PubMed ID: 25517595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
    Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.
    Jess T; Simonsen J; Nielsen NM; Jørgensen KT; Bager P; Ethelberg S; Frisch M
    Gut; 2011 Mar; 60(3):318-24. PubMed ID: 21193449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
    Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of inflammatory bowel disease in Québec residents with airway diseases.
    Brassard P; Vutcovici M; Ernst P; Patenaude V; Sewitch M; Suissa S; Bitton A
    Eur Respir J; 2015 Apr; 45(4):962-8. PubMed ID: 25406447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.
    King D; Reulen RC; Thomas T; Chandan JS; Thayakaran R; Subramanian A; Gokhale K; Bhala N; Nirantharakumar K; Adderley NJ; Trudgill N
    Aliment Pharmacol Ther; 2020 May; 51(10):922-934. PubMed ID: 32237083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegaloviral enterocolitis: clinical associations and outcome.
    Kaufman HS; Kahn AC; Iacobuzio-Donahue C; Talamini MA; Lillemoe KD; Hamilton SR
    Dis Colon Rectum; 1999 Jan; 42(1):24-30. PubMed ID: 10211516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.
    Nolla-Salas J; Codina-Calero J; Vallés-Angulo S; Sitges-Serra A; Zapatero-Ferrándiz A; Climent MC; Gómez J; Masclans JR
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1393-1403. PubMed ID: 28258303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
    Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
    Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study].
    Lopez Miguel C; Sicilia B; Sierra E; Lopez Zaborras J; Arribas F; Gomollon F
    Gastroenterol Hepatol; 1999; 22(7):323-8. PubMed ID: 10535203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.